Overview

Study of DU-176b Aged 80 Years or Older

Status:
Completed

Trial end date:
2019-12-27

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of edoxaban in patients with non-valvular NVAF aged 80 years or older who are ineligible for available oral anticoagulation therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Daiichi Sankyo Co., Ltd.

Treatments:

Edoxaban